MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Refining and Understanding Causal Relationships between Brain Imaging-Derived Phenotypes and Parkinson’s Disease: a Bidirectional Mendelian Randomization Study and Clinical Validation

    M. Niu, Y. Zhang (Shanghai, China)

    Objective: Utilizing bidirectional two-sample Mendelian randomization, we explored the causal associations between imaging-derived phenotypes (IDPs) and Parkinson's Disease (PD), along with its manifestations. Background: Observational…
  • 2024 International Congress

    Longitudinal Structural and Functional Correlates of Progression in Isolated Rapid Eye Movement Sleep Behaviour Disorder

    L. Churchill, YC. Chen, J. Anderson, A. Ignatavicius, SJG. Lewis, E. Elie (Camperdown, Australia)

    Objective: To identify progressive structural and functional imaging alterations in a longitudinal cohort of patients with isolated rapid eye movement sleep behavior disorder (iRBD). Background:…
  • 2024 International Congress

    First in vivo evidence of the role of the noradrenergic system in olfactory dysfunction in Parkinson’s disease

    C. Laurencin, S. Lancelot, S. Brosse, J. Redouté, I. Mérida, D. Le Bars, N. Costes, S. Thobois, P. Boulinguez, B. Ballanger (lyon, France)

    Objective: To investigate the relationship between in vivo noradrenergic markers and olfactory impairment in patients with Parkinson’s disease (PD). Background: Degeneration of the noradrenergic (NA)…
  • 2024 International Congress

    Enlarged Perivascular Spaces in the Temporal Lobe as a Predictor for Incident Dementia in Parkinson’s Disease

    HK. Na, Y. Sun, JH. Lee, CW. Park, YH. Sohn, CH. Lyoo, PH. Lee (Seoul, Republic of Korea)

    Objective: To evaluate the whether regional burden of enlarged perivascular space (EPVS) hold prognostic value in predicting the dementia conversion in Parkinson's disease (PD). Background:…
  • 2024 International Congress

    Evaluating Fall Risk in People with Parkinson’s Disease Using a Novel Comprehensive Posturography Assessment

    P. Carlson-Kuhta, C. Silva-Batista, A. Ragothaman, M. Abdollahi, J. Ellison, G. Harker, G. Marchesi, A. de Luca, V. Squeri, F. Horak, M. Mancini (Portland, USA)

    Objective: To determine if a comprehensive balance assessment on a posturography system can identify retrospective Fallers from Non-fallers in people with Parkinson’s disease (PwPD). We…
  • 2024 International Congress

    Effects of striatal dopamine depletion and altered brain metabolism on Parkinson’s disease

    HS. Yoo, PH. Lee, CH. Lyoo (Seoul, Republic of Korea)

    Objective: To investigate the relationship between striatal dopamine depletion, altered brain metabolism, motor deficits, and cognitive dysfunction in Parkinson’s disease (PD) Background: PD shows degeneration…
  • 2024 International Congress

    Automated Imaging Differentiation of Parkinsonism (AIDP): A Prospective 21-site Trial within the Parkinson’s Study Group

    D. Vaillancourt, A. Barmpoutis, R. Chen, J. Desimone, M. Schauder, W. Wang, T. Parish, R. Fang, M. Okun (Gainesville, USA)

    Objective: To prospectively test the performance of Automated Imaging Differentiation of Parkinsonism (AIDP), a machine learning based diagnostic biomarker software for Parkinson’s disease (PD), multiple system atrophy Parkinsonian…
  • 2024 International Congress

    Clinical and Brain Morphological Characteristics of Early LRRK2-associated Parkinson Disease

    Q. Tao, S. Rahayel, C. Tremblay, A. Vo, A. Dagher (Montreal, Canada)

    Objective: To investigate the impact of LRRK2 mutation in Parkinson disease (PD) and to explore the preclinical markers of LRRK2 mutation carriers who will develop…
  • 2024 International Congress

    MIBG Uptake in the Major Salivary Glands in Patients with Parkinson’s Disease and Dementia with Lewy Bodies

    J. Ebina, S. Mizumura, H. Morioka, M. Shibukawa, J. Nagasawa, M. Yanagihashi, T. Hirayama, N. Ishii, Y. Kobayashi, A. Inaba, S. Orimo, O. Kano (Tokyo, Japan)

    Objective: The aim of the study was to compare the metaiodobenzylguanidine (MIBG) uptake in the major salivary glands (MSG) in patients with Parkinson’s disease (PD)…
  • 2024 International Congress

    Characterising early morning akinesia and off (EMO) using Parkinson’s kinetigraph: analysis from a two centre national database in Parkinson’s disease .

    K. Poplawska-Domaszewicz, D. Trivedi, K. Ray Chaudhuri (Poznan, Poland)

    Objective: Could wearable sensors such as Parkinson’s kinetograph (PKG) may provide valuable overnight data to detect EMO to augment care in clinic. Background: Early morning…
  • « Previous Page
  • 1
  • …
  • 148
  • 149
  • 150
  • 151
  • 152
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • An atypical and interesting feature of Parkinson´s disease
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley